EMN vs PDEX · P/E 21, rev $9.38B vs P/E 16, rev $77.5M
Eastman Chemical Company (EMN) versus Pro-Dex Inc (PDEX) — a side-by-side from cached financials, not a winner call.
Eastman Chemical Company (EMN) is a specialty chemicals company listed on US.
Pro-Dex Inc (PDEX) is a medical instruments & supplies company listed on US.
Latest reported EMN revenue for 2024-12-31 was $9.38B. Net income was $908.0M. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
Latest reported PDEX revenue for 2026-06-30 was $77.5M. Net income was $13.7M. Revenue was up 16.5% from 2025-06-30 to 2026-06-30. PDEX currently screens at market cap $146.4M and trailing P/E 16.3.
EMN currently screens at market cap $8.21B and trailing P/E 20.8. PDEX currently screens at market cap $146.4M and trailing P/E 16.3.
Not investment advice. Open the EMN and PDEX stock pages for the full models.
Not investment advice.